Polymer Capital Management (US) LLC

Source: SEC Form 13F · as of Mar 2026

Polymer Capital Management (US) LLC holds 49 biotech & pharma companies tracked by BioSniper, totaling $18.7M in value as of Mar 2026 (SEC Form 13F).

Companies held

49

Total value held

$18.7M

CompanySharesValue
CORCencora Inc.4,624$1.5M
INCYIncyte Corp.11,691$1.1M
REGNREGENERON PHARMACEUTICALS, INC.1,382$1.1M
BMRNBIOMARIN PHARMACEUTICAL INC17,104$966K
GMOptec International, Inc.12,024$896K
NBIXNEUROCRINE BIOSCIENCES INC6,290$829K
VRTXVERTEX PHARMACEUTICALS INC / MA1,669$745K
MRNAModerna, Inc.13,968$710K
MCKMcKesson Corporation757$655K
DNTHDianthus Therapeutics, Inc. /DE/7,339$616K
LLYELI LILLY & Co649$597K
RIOTRiot Platforms, Inc.45,830$566K
MOHMolina Healthcare Inc4,150$553K
DAWNDay One Biopharmaceuticals, Inc.24,872$533K
GEHCGE HealthCare Technologies Inc.7,237$515K
VTRSViatris Inc33,324$450K
ZTSZoetis Inc.3,757$444K
GILDGILEAD SCIENCES, INC.2,662$371K
BMYBRISTOL MYERS SQUIBB CO6,023$365K
MEDPMedpace Holdings Inc.740$355K
MRKMerck & Co., Inc.2,536$305K
VIRVir Biotechnology, Inc.33,565$301K
PGNYProgyny Inc.17,373$295K
ABTABBOTT LABORATORIES2,831$291K
NATRNATURES SUNSHINE PRODUCTS INC12,066$289K
INSPInspire Medical Systems Inc.5,583$288K
INDVIndivior Pharmaceuticals, Inc.8,240$251K
ALLOAllogene Therapeutics, Inc.100,676$246K
QGENQIAGEN N.V.6,077$243K
UNHUnitedHealth Group Incorporated Common Stock (DE)896$242K
JNJJOHNSON & JOHNSON896$219K
FLGTFulgent Genetics Inc.12,967$206K
BIOABioAge Labs, Inc.11,688$204K
BCRXBIOCRYST PHARMACEUTICALS INC21,353$203K
RGNXREGENXBIO Inc.23,752$199K
ZVRAZEVRA THERAPEUTICS, INC.14,109$131K
RXRXRECURSION PHARMACEUTICALS, INC.39,883$122K
VSTMVerastem, Inc.17,120$91K
REPLReplimune Group, Inc.11,764$90K
INNVINNOVUS PHARMACEUTICALS, INC.10,843$87K
GERNGERON CORP57,534$86K
CRMDCorMedix Inc.12,518$85K
MDXGMiMedx Group Inc20,388$81K
IOVAIOVANCE BIOTHERAPEUTICS, INC.22,764$80K
MNKDMANNKIND CORP32,183$79K
ALTAltimmune, Inc.23,999$74K
CATXPerspective Therapeutics, Inc.13,083$55K
PRMEPrime Medicine, Inc.10,317$36K
AKBAAkebia Therapeutics, Inc.21,394$30K

13F holdings reflect long positions in U.S.-listed securities as reported to the SEC. Values are point-in-time for the most recent reported quarter.